Tehran University of Medical Sciences

Science Communicator Platform

Share By
Specific Immunotherapy in Ovarian Cancer: A Systematic Review Publisher Pubmed



Alipour S1 ; Zoghi S1 ; Khalili N1 ; Hirbodmobarakeh A1, 2, 3 ; Emens LA4 ; Rezaei N2, 3, 5
Authors

Source: Immunotherapy Published:2016


Abstract

Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer. Several approaches of active and passive immunotherapy for EOC have been studied. The aim of this systematic review was to assess the clinical efficacy of specific immunotherapy in patients with EOC. We found 4524 references in seven databases and we included ten controlled clinical trials with 2285 patients with EOC reporting five active immunotherapeutic agents and three passive immunotherapies. Meta-analysis of six studies showed that overall there was not any significant difference in overall survival and recurrence-free survival between patients undergoing specific immunotherapy and those in control group. Most of the studies we evaluated reported a positive outcome from treatment with specific immunotherapy, although this was not significant. © 2016 Future Medicine Ltd.
Related Docs
View other Related Docs
1. Specific Immunotherapy in Hepatocellular Cancer: A Systematic Review, Journal of Gastroenterology and Hepatology (Australia) (2017)
2. Specific Immunotherapy in Renal Cancer: A Systematic Review, Therapeutic Advances in Urology (2017)
3. Breast Cancer Immunotherapy: Current and Novel Approaches, International Immunopharmacology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (2)
Amir Kasaeian (1)
Other Related Docs
4. Blockade of Nuclear Factor-Κb (Nf-Κb) Pathway Inhibits Growth and Induces Apoptosis in Chemoresistant Ovarian Carcinoma Cells, International Journal of Biochemistry and Cell Biology (2018)
5. Combination of Immune Checkpoint Inhibitors and Radiotherapy in Locally Advanced Esophagogastric Junction Adenocarcinoma: A Review, Cancer (2024)
6. Immunotherapeutic Approaches for Cancer Therapy: An Updated Review, Artificial Cells# Nanomedicine and Biotechnology (2016)
7. The Therapeutic Potential of Targeting Tumor Microenvironment and Modulation of Immunotherapy in Gastrointestinal Cancer, Current Cancer Drug Targets (2025)
8. Outcomes With Immunotherapy in Hormone Receptor-Positive Breast Cancer: A Systematic Review and Meta-Analysis, American Journal of Clinical Oncology: Cancer Clinical Trials (2026)